[[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].
Mühlhoff
C
C
Klinik für Dermatologie und Allergologie, Universitätsklinikum der RWTH Aachen, Pauwelsstrasse 30, 52057 Aachen. cmuehlhoff@ukaachen.de
Megahed
M
M
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D002985:Clinical Protocols; D019085:Fluorescent Antibody Technique, Direct; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab